Top

Published in:

01-09-2019 | Case Report

Gallbladder Cancer: Complete Resection after Second Line Treatment in Stage IV Disease

Authors: Maria Castelo Branco, Fernanda Estevinho, João Correia Pinto, Mrinalini Honavar, Carlos Raposo, Ana Catarina Silva, Carlos Sottomayor

Published in: Journal of Gastrointestinal Cancer | Issue 3/2019

Excerpt

Gallbladder carcinoma is rare, with an incidence of 1.6–2.0/100,000 in Western Europe; however, it is the most common cancer of the biliary tract accounting for 80–95% of these cancers [1‐3]. It is far more common in central Europe, Chile, India, Korea, and Japan. The incidence increases with age and it is more common in women. …

Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE. Abeloff's clinical oncology. 5th ed. Philadelphia: Elsevier; 2014. p. 1373–96.

Eckel F, Brunner T, Jelic S. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2016;27(supplement 5):v28–37. https://doi.org/10.1093/annonc/mdw324.CrossRef

NCCN Guidelines hepatobiliary cancers, version 2.2016.

Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol. 2000;95(6):1402–10. https://doi.org/10.1111/j.1572-0241.2000.02070.x.CrossRefPubMed

Shrikhande SV, Barreto SG, Singh S, Udwadia TE, Agarwal AK. Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause. Eur J Surg Oncol. 2010;36(6):514–9. https://doi.org/10.1016/j.ejso.2010.05.002.CrossRefPubMed

Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99–109. https://doi.org/10.2147/CLEP.S37357.CrossRefPubMedPubMedCentral

Eckel F, Schmid RM. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer. 2007;96(6):896–902. https://doi.org/10.1038/sj.bjc.6603648.CrossRefPubMedPubMedCentral

Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. ABC-02 trial investigators cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273–81. https://doi.org/10.1056/NEJMoa0908721.CrossRefPubMed

Yang R, Wang B, Chen YJ, et al. Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a metanalysis. Anti-Cancer Drugs. 2013;24(8):871–7. https://doi.org/10.1097/CAD.0b013e3283637292.CrossRefPubMed

10.

Cho JY, Paik YH, Chang YS. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer. 2005;104(12):2753–8. https://doi.org/10.1002/cncr.21591.CrossRefPubMed

11.

Knox J, Hedley D, Oza A, et al. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. JCO. 2005;23(10):2332–8. https://doi.org/10.1200/JCO.2005.51.008.CrossRef

12.

Riechelmann RP, Townsley CA, Chin SN, Pond GR, Knox JJ. Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer. Cancer. 2007;110(6):1307–12. https://doi.org/10.1002/cncr.22902.CrossRefPubMed

13.

Iqbal S, Rankin C, Lenz H, et al. A phase II trial of gemcitabine and capecitabine in patients with unressectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group Study S0202. Cancer Chemother Pharmacol. 2011;68(6):1595–602. https://doi.org/10.1007/s00280-011-1657-1.CrossRefPubMedPubMedCentral

14.

Fiteni F, Nguyen T, Vernerey D, Paillard M, et al. Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review. Cancer Med. 2014;3(6):1502–11. https://doi.org/10.1002/cam4.299.CrossRefPubMedPubMedCentral

15.

Nishio H, Nagino M, Ebata T, Yokoyama Y, Igami T, Nimura Y. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepato-Biliary-Pancreat Surg. 2007;14(4):351–7. https://doi.org/10.1007/s00534-006-1187-0.CrossRef

16.

Kang MJ, Song Y, Jang J, et al. Role of radical surgery in patients with stage IV gallbladder cancer. HPB. 2012;14(12):805–11. https://doi.org/10.1111/j.1477-2574.2012.00544.x.CrossRefPubMedPubMedCentral

17.

Creasy JM, Goldman DA, Dudeja V, Lowery MA, Cercek A, Balachandran VP, et al. Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes. J Am Coll Surg. 2017;224(5):906–16. https://doi.org/10.1016/j.jamcollsurg.2016.12.058.CrossRefPubMedPubMedCentral

Title: Gallbladder Cancer: Complete Resection after Second Line Treatment in Stage IV Disease
Authors: Maria Castelo Branco
Fernanda Estevinho
João Correia Pinto
Mrinalini Honavar
Carlos Raposo
Ana Catarina Silva
Carlos Sottomayor
Publication date: 01-09-2019
Publisher: Springer US
Published in: Journal of Gastrointestinal Cancer / Issue 3/2019
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-017-0044-5

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Gallbladder Cancer: Complete Resection after Second Line Treatment in Stage IV Disease

Excerpt

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2019

Desmoplastic Small Round Cell Tumor: A Rare Case of Extraluminal Bowel Obstruction and Review of the Literature

Outcomes of Definitive Chemoradiotherapy for Cervical and Upper Thoracic Esophageal Cancers: a Single-Institution Experience of a Rare Cancer

Superficially Spreading Signet-Ring Cell Carcinoma Perpendicularly Colliding with Gastric Adenoma: a Rare Case Report

Total Pancreatectomy with Islet Autotransplantation for the Ampullary Cancer. A Case Report

Colorectal Cancer-Associated Spontaneous Tumor Lysis Syndrome: a Case Report and Review of the Current Literature

Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page